Stocks · Health care · Services-Commercial Physical & Biological Research

Incyte

INCY Clue Score71
United States Fiscal year ends December CIK 0000879169 Results filed 29 Oct 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Thomas Tray
3 Nov 2026
Principal Accounting Officer
Sold on a plan
610
$118.96
$72.57K
Pablo J Cagnoni
15 Oct 2026
President, Global Head of R&D
Sold after exercise
2,642
$112.71
$297.78K
Pablo J Cagnoni
15 Sep 2026
President, Global Head of R&D
Sold after exercise
13,985
$120.49
$1.69M
Pablo J Cagnoni
15 Sep 2026
President, Global Head of R&D
Sold after exercise
9,233
$120.50
$1.11M
Pablo J Cagnoni
19 Aug 2026
President, Global Head of R&D
Sold on a plan
10,801
$125.56
$1.36M
Pablo J Cagnoni
12 Aug 2026
President, Global Head of R&D
Sold on a plan
10,803
$120.04
$1.30M
Patrick A Mayes
5 Aug 2026
EVP & Chief Scientific Officer
Sold after exercise
2,207
$123.99
$273.65K
Pablo J Cagnoni
5 Aug 2026
President, Global Head of R&D
Sold on a plan
10,640
$122.69
$1.31M
Patrick A Mayes
3 Aug 2026
EVP & Chief Scientific Officer
Sold after exercise
6,055
$120.43
$729.20K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,293
$119.41
$273.81K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
326
$121.69
$39.67K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
85
$122.19
$10.39K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
1,642
$119.38
$196.02K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
1,643
$119.51
$196.35K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,864
$119.40
$341.96K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
4,695
$119.39
$560.54K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
6,171
$119.43
$737.00K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,187
$119.47
$261.28K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
5,332
$119.42
$636.75K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
14,661
$119.46
$1.75M
Pablo J Cagnoni
31 Jul 2026
President, Global Head of R&D
Sold on a plan
15,888
$119.70
$1.90M
Mohamed Khairie Issa
16 Jul 2026
EVP, Head of U.S. Commercial
Sold on a plan
1,093
$115.01
$125.71K
Steven H Stein
16 Jul 2026
CMO & Head of Late-Stage Dev.
Sold on a plan
1,877
$114.73
$215.35K
Steven H Stein
15 Jul 2026
CMO & Head of Late-Stage Dev.
Sold on a plan
28,237
$113.05
$3.19M
Thomas Tray
4 Jun 2026
Principal Accounting Officer
Sold after exercise
2,639
$100.00
$263.90K
Jean Jacques Bienaime
26 May 2026
Director
Exercised, kept
15,000
$84.53
$1.27M
Thomas Tray
26 May 2026
Principal Accounting Officer
Sold on a plan
2,051
$97.35
$199.66K
Paul J Clancy
19 May 2026
Director
Sold after exercise
15,000
$94.93
$1.42M
Baker Bros. Advisors LP
8 May 2026
Director
Exercised, kept indirect
15,000
$84.53
$1.27M
Baker Bros. Advisors LP
8 May 2026
Director
Exercised, kept indirect
15,000
$84.53
$1.27M
Pablo J Cagnoni
17 Apr 2026
President, Global Head of R&D
Sold after exercise
18,667
$96.50
$1.80M
Pablo J Cagnoni
17 Mar 2026
President, R&D
Sold after exercise
18,667
$94.24
$1.76M
Pablo J Cagnoni
19 Feb 2026
President, R&D
Sold after exercise
18,668
$100.91
$1.88M
Mohamed Khairie Issa
7 Jan 2026
EVP, Head of US Oncology
Sold on a plan
10,856
$109.07
$1.18M
Steven H Stein
5 Jan 2026
EVP & Chief Medical Officer
Sold on a plan
15,634
$101.70
$1.59M
Thomas Tray
19 Dec 2025
Principal Accounting Officer
Sold after exercise
2,774
$100.00
$277.40K
Thomas Tray
18 Dec 2025
Principal Accounting Officer
Sold on a plan
600
$98.25
$58.95K
Michael James Morrissey
17 Dec 2025
EVP, Head of Tech. Operations
Sold on a plan
4,323
$97.26
$420.45K
Michael James Morrissey
16 Dec 2025
EVP, Head of Tech. Operations
Sold on a plan
53,175
$97.29
$5.17M
Michael James Morrissey
16 Dec 2025
EVP, Head of Tech. Operations
Sold on a plan
833
$97.42
$81.15K
Patrick A Mayes
11 Dec 2025
EVP & Chief Scientific Officer
Sold on a plan
255
$94.94
$24.21K
Patrick A Mayes
10 Dec 2025
EVP & Chief Scientific Officer
Sold on a plan
5,553
$95.58
$530.76K
Steven H Stein
2 Dec 2025
EVP & Chief Medical Officer
Sold on a plan
20,105
$102.51
$2.06M
Steven H Stein
1 Dec 2025
EVP & Chief Medical Officer
Sold on a plan
2,559
$102.96
$263.47K
Thomas Tray
24 Nov 2025
Principal Accounting Officer
Sold on a plan
600
$103.00
$61.80K
Thomas Tray
21 Nov 2025
Principal Accounting Officer
Sold on a plan
169
$102.00
$17.24K
Sheila A. Denton
17 Nov 2025
EVP & General Counsel
Sold after exercise
278
$104.36
$29.01K
Herve Hoppenot
10 Nov 2025
Director
Sold on a plan
187,500
$105.46
$19.77M

What was left out

Form 4 filings counted 91
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 22
Sales straight out of an exercise 23
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 688,231
History held since 13 Oct 2006